Sonoma Pharmaceuticals Inc (SNOA.OQ)
14 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|53||2013||President, Chief Executive Officer, Director|
|59||2014||Executive Vice President - Research and Development|
|52||2008||Executive Vice President - International Operations and Sales|
|2017||Chief Strategy and Marketing Officer|
|73||2013||Chief Financial Officer, Chief Operating Officer, Secretary|
- BRIEF-Sonoma Pharmaceuticals announces second FDA approval to add antimicrobial language to alevicyn gel products
- BRIEF-Sonoma Pharmaceuticals announces FDA approval of expanded indication for Alevicyn
- BRIEF-Sonoma Pharmaceuticals files for mixed shelf of upto $75 mln - SEC filing
- BRIEF-Sonoma Pharmaceuticals posts Q2 loss $0.67/shr from continuing operations
- BRIEF-Sonoma Pharmaceuticals receives Brazilian approvals